Search Results: C-THR88-2405 Valid Vce 🦊 C-THR88-2405 Practice Test Online 🎶 Guaranteed C-THR88-2405 Questions Answers 🕑 Easily obtain ➤ C-THR88-2405 ⮘ for free download through ☀ www.pdfvce.com ️☀️ 😒C-THR88-2405 Valid Test Vce Free

Frequently asked questions How can we help you? Cell3 Preserver Tube Bead Xtract cfDNA Kit Cell3 Xtract Kit Cell3 Direct: RhD fetal genotyping Cell3 Target: Library preparation Cell3 Preserver Tube What is the shelf life of Cell3 Preserver Tubes once they have been delivered? They have a three month shelf life once the pouch has…

Non-invasive prenatal genetic testing Cell3™ Target: Custom Prenatal Panels Reliable targeted enrichment developed for prenatal testing and diagnosis using cell-free fetal DNA (cffDNA) or genomic DNA (gDNA). Request a quote Product datasheet Validated for cell-free and genomic DNA Next generation sequencing (NGS) enrichment developed for and validated on cell-free DNA as well as gDNA for…

Specialized cell-free DNA blood collection tubes Cell3™ Preserver Pre-analytical blood collection tubes for liquid biopsy, validated for collection of whole blood and stabilization of cell-free DNA and circulating tumor DNA for up to 15 days. Request a quote Product datasheet Long cell stability Stabilizes whole blood for up to 15 days post blood draw, making…

A non-invasive comprehensive biomarker test for bladder cancer GALEASTM Bladder A novel bladder cancer test providing a non-invasive, sample-to-report, molecular triage for patients with hematuria. Request a quote Product datasheet A non-invasive NGS alternative to cystoscopy for ALL stages of bladder cancer   Bladder cancer is the 5th most common cancer in the western world…

NGS-based urine bladder cancer test GALEAS™ Bladder A non-invasive NGS-based molecular test for identifying bladder cancer from a urine sample Request a quote Product datasheet   GALEAS Bladder is a simple, sample-to-report urine test to detect the presence of bladder cancer. GALEAS Bladder leverages ultra-sensitive, targeted next generation sequencing (NGS) chemistry to interrogate somatic mutations…

Our Cell3™ Target Technology High performing, easy to use, targeted NGS enrichment solutions for cell-free and genomic DNA Oncology products Germline products Custom panels Superior on-target rates and exceptional uniformity of coverage Ultimate sensitivity for variant detection down to 0.1% VAF Suitable for use with cell-free DNA (cfDNA), genomics DNA (gDNA) or formalin-fixed paraffin-embedded DNA…

Panel Design Tool Create custom next generation sequencing (NGS) panels online in minutes. Start your design Your design in your hands Complete design control Our online software means you can create a panel design, get target coverage information and request a quote in minutes. Flexible input files From BED files, gene lists or genomic coordinates,…

Detect SNVs, INDELs and CNVs in a single, clinical-grade assay Cell3™ Target: Nexome Capture more variants and increase your diagnostic yield.   Request a quote Product datasheet Features Empower informed prenatal decisions  Nexome’s enhanced prenatal testing capabilities provide a more thorough assessment of fetal health. This empowers expectant parents and healthcare providers to make informed…

GALEAS™ Software Services Terms of Use Version 1.3 0 last updated 8 March 2024 (A) ‘Customer’ means the person or entity who has agreed to these Terms of Use. (B) ‘Nonacus’ means Nonacus Limited, a company incorporated in England and Wales with registered number 9590278 whose registered office is at Unit 5, Quinton Business Park,…

Terms and Conditions When we do business with you, the standard terms and conditions below are an important part of the contract between you, the customer, and Nonacus. They set out each of our legal rights and responsibilities, and other information required by law. Some important points are: Purchase orders must quote the relevant design…